BRPI0017420B8 - composição de vacina, hpv 16 l1 e hpv 18 l1 vpl - Google Patents

composição de vacina, hpv 16 l1 e hpv 18 l1 vpl

Info

Publication number
BRPI0017420B8
BRPI0017420B8 BRPI0017420A BRPI0017420A BRPI0017420B8 BR PI0017420 B8 BRPI0017420 B8 BR PI0017420B8 BR PI0017420 A BRPI0017420 A BR PI0017420A BR PI0017420 A BRPI0017420 A BR PI0017420A BR PI0017420 B8 BRPI0017420 B8 BR PI0017420B8
Authority
BR
Brazil
Prior art keywords
antigen
hpv
vaccine composition
vpl
hepatitis
Prior art date
Application number
BRPI0017420A
Other languages
English (en)
Inventor
Mohammed Slaoui Moncef
Original Assignee
Smithkline Beecham Biologicals S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9921146A external-priority patent/GB9921146D0/en
Application filed by Smithkline Beecham Biologicals S A filed Critical Smithkline Beecham Biologicals S A
Publication of BRPI0017420B1 publication Critical patent/BRPI0017420B1/pt
Publication of BRPI0017420B8 publication Critical patent/BRPI0017420B8/pt

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

composição de vacina. novas composições de vacina combinada são fornecidas, compreendendo um antígeno de vírus simplex de herpes (hsv) e um antígeno hpv e opcionalmente em adição um ou mais dos seguintes: um antígeno ebv, um antígeno de hepatite a ou vírus atenuado desativado, um antígeno viral de hepatite b, um antígeno vzv , um antígeno hcmv, um antígeno de toxoplasma gondii. as composições de vacina são formuladas com um adjuvante que é um estimulador preferencial de resposta de célula th1 tal como 3d-mpl e qs21.
BRPI0017420A 1999-09-07 2000-09-07 composição de vacina, hpv 16 l1 e hpv 18 l1 vpl BRPI0017420B8 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9921146A GB9921146D0 (en) 1999-09-07 1999-09-07 Novel composition
GB99211146.8 1999-09-07
BRPI0014171 2000-09-07
PCT/EP2000/008784 WO2001017551A2 (en) 1999-09-07 2000-09-07 Combined vaccine compositions

Publications (2)

Publication Number Publication Date
BRPI0017420B1 BRPI0017420B1 (pt) 2020-10-06
BRPI0017420B8 true BRPI0017420B8 (pt) 2021-05-25

Family

ID=73024915

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0017420A BRPI0017420B8 (pt) 1999-09-07 2000-09-07 composição de vacina, hpv 16 l1 e hpv 18 l1 vpl

Country Status (1)

Country Link
BR (1) BRPI0017420B8 (pt)

Also Published As

Publication number Publication date
BRPI0017420B1 (pt) 2020-10-06

Similar Documents

Publication Publication Date Title
BR0014171A (pt) Composição
MY135965A (en) Vaccine against hepatitis b and herpes simplex virus
BR0014172A (pt) Composição
JP2003508495A5 (pt)
BR9814606A (pt) Formulação de vacina e métodos de tratamento de um indivìduo infectado com um vìrus hpv e de prevenção de infecção por papiloma vìrus
ES2070997T3 (es) Virus de herpes recombinante de pavos y vacunas vector vivas derivadas de los mismos.
BR0014386A (pt) Composição
MY134041A (en) Novel composition
WO2000053729A3 (de) Virale partikel, die nach infektion durch humanes cytomegalovirus freigesetzt werden und ihre verwendung als impfstoff
WO2002012288A3 (en) Vaccination against host cell-associated herpesviruses
BRPI0017420B8 (pt) composição de vacina, hpv 16 l1 e hpv 18 l1 vpl
HUP0102861A2 (hu) Attenuált lóherpeszvírus
BR0014861A (pt) Partìculas virais com epìtopos internos exógenos
AR041249A2 (es) Una composicion de vacuna
DE60035695D1 (de) Schutzantigen des epstein-barr-virus
HUP0002374A2 (hu) Egy diszfunkcionális 71 gén régiót tartalmazó rekombináns 1-es típusú ló herpeszvírus (EHV-1) és alkalmazása vakcinaként
TH31643A (th) การปรับปรุงเซลล์ ไลน์ที่สนับสนุนสำหรับการผลิตวัคซีนป้องกันโรคมาเรกส์

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: PARA QUE A SOLICITACAO REQUERIDA NA PETICAO NO 020070021179/RJ DE 16/02/2007 SEJA ATENDIDA, APRESENTE DECLARACAO DE INCLUSAO E EXCLUSAO DE INVENTOR, NA QUAL DEVEM SE MANIFESTAR OS INTERESSADOS.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 06/10/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 07/09/2000 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 07/09/2020